Cultivated Peanut AhPR10 Gene Family Plays Key Role in Resistance to Aspergillus Flavus

Why It Matters

The ability to breed peanuts that naturally resist A. flavus reduces reliance on chemical controls and lowers aflatoxin risk, protecting consumer health and export markets.

Key Takeaways

• AhPR10 genes upregulated during A. flavus infection
• CRISPR knockout reduces resistance, confirming functional role
• Marker-assisted breeding targets AhPR10 for aflatoxin mitigation
• Expression correlates with lower aflatoxin levels in field trials
• Findings enable biotech strategies for safer peanut production

Pulse Analysis

Aflatoxin contamination remains one of the most persistent threats to global peanut production, driving costly recalls and limiting access to high‑value export markets. While post‑harvest interventions have mitigated some risk, the industry has long sought a genetic solution that can block Aspergillus flavus infection at the source. Recent advances in plant genomics have highlighted pathogenesis‑related (PR) proteins as frontline defenders, yet few have been directly linked to aflatoxin resistance in legumes.

In a breakthrough study, scientists dissected the AhPR10 gene family across diverse cultivated peanut lines, uncovering a pattern of rapid transcriptional activation when the plants encountered A. flavus spores. Using CRISPR‑Cas9 to silence individual AhPR10 members, the team demonstrated a measurable increase in fungal colonization, confirming that these genes actively suppress pathogen growth. Moreover, genome‑wide association mapping pinpointed specific AhPR10 alleles that correlate with reduced aflatoxin accumulation in field trials, offering a tangible genetic marker for selection.

The practical implications are immediate. Breeders can now incorporate AhPR10‑linked markers into marker‑assisted selection pipelines, accelerating the development of varieties that combine high yield with intrinsic fungal resistance. Biotech firms may also leverage the identified promoters to engineer transgenic or gene‑edited peanuts with enhanced PR10 expression, further lowering reliance on fungicides. As regulatory frameworks tighten around aflatoxin limits, these innovations promise to safeguard consumer health, stabilize supply chains, and open new premium markets for aflatoxin‑free peanuts.